A- A A+

Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in the setting of injectable opioid agonist treatment in Canada: a case report. 

Palis, H., MacDonald, S., Jun, J. et al. 

Harm Reduct J 18, 57 (2021). doi.org/10.1186/s12954-021-00500-9

https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-021-00500-9